EQS-News
BRAIN Biotech AG: BRAIN Biotech AG´s Akribion Genomics team wins first prize at the “BioRiver Boost!” startup competition - Seite 2
Michael Krohn, one of the two designated CEOs of Akribion Genomics, says: “Winning the first prize in this competition has been a great success for all of us. The confirmation from the experienced jury that our project has a high probability of success and great potential for development into a marketable technology was a major factor in this. A big thank you goes to the jury and to the organizers at BioRiver – this was a great event!”
+++
Photo for the press: (download: https://www.brain-biotech.com/press )
Capture: From left to right: Dr. Frauke Hangen (BioRiver), Andreas Reichert (Lumatix), Dr Oliver Grünvogel (Akribion Genomics), Dr. Bettina Möckel (Qiagen) and Dr Michael Krohn (Akribion
Genomics) at the BioRiver Boost! 2023 award ceremony in Monheim. BioRiver – Life Science im Rheinland e.V.
About Akribion Genomics
As a brand name of BRAIN Biotech AG, Akribion Genomics focuses on developing groundbreaking CRISPR nucleases into a new class of genetics-based cancer therapies and advanced genome editing tools,
powered by the BRAIN Biotech Group BioIncubator. Akribion Genomics’ flexible CRISPR-based gene editing technology platform features distinct technology families (G-dases) with broad application in
Industrial Biotechnology and Agriculture, and offers a groundbreaking technological advantage for therapeutic and diagnostic solutions.
Akribion Genomics is committed to using its technology with high ethical standards to improve products, processes and medical treatments. Its goal is to develop new treatment approaches in oncology
by employing novel CRISPR technology that allows targeted cell depletion using RNA biomarkers. In addition, access to advanced CRISPR genome editing technology with freedom-to-operate will be made
more feasible.
Akribion Genomics is a spin-off in founding of BRAIN Biotech AG, a renowned international group of companies providing innovative biobased products and solutions to industry.
For additional information, please visit www.akribion-genomics.com and LinkedIn
Lesen Sie auch
About BRAIN Biotech
BRAIN Biotech AG is a leading European supplier of biobased products and solutions such as enzymes and proteins, microbial production strains, natural compounds and biotechnological solutions for
more sustainable industrial processes. The company focuses on the fields of nutrition, health and environment.